Abstract
Background and Objectives:
Escherichia coli is known to be the pathogen commonly isolated from those infected with urinary tract infections (UTIs). The aim of this study was to investigate the presence of E. coli virulence genes and antibiotics’ resistance pattern among clinical isolates in the Northeast of Iran. Relationships between virulence genes and antimicrobial resistances were studied as well.
Materials and Methods:
Three hundred isolates of E. coli were isolated from patients with UTIs that referred to Ghaem and Imam Reza hospitals (Mashhad, Iran) during August 2016 to February 2017. A multiplex PCR was employed to amplify the genes encoding pyelonephritis associated pili (pap), S-family adhesions (sfa), type1fimbriae (fimH) and aerobactin (aer). Disk diffusion test was performed to test the susceptibility of isolates to β-lactams, aminoglycosides, cephalosporins, quinolone, fluoroquinolones, carbapenems and trimethoprim-sulfamethoxazole.
Results:
The PCR results identified the fimH in 78.4%, aer in 70.5%, sfa in 13.6% and the pap in 8.2% of isolates. The rates of antibiotic resistance of the isolates were as follows: 64.7% resistant to cephalosporins, 34% to trimethoprim-sulfamethoxazole, 31% to fluoroquinolones, 15.3% to aminoglycosides, 13.3% to β-lactams, 7.8% to quinolones and 4.4% to carbapenems. Significant relationships existed between pap and aer, pap and sfa, aer and fluoroquinolones also pap and cephalosporins.
Conclusion:
fimH and aer were found in > 50% of isolates suggesting the importance of both genes in UPEC. The majority of isolates had fimH as adhesion factor for colonization. Determining antibiotic resistance patterns in specific geographical areas is necessary for appropriate treatment of urinary tract infection. The high rate of resistance to cephalosporins is most likely due to incorrect drug administration.
Keywords: Urinary tract infections, Escherichia coli, Virulence factor, Multiplex polymerase chain reaction, Antibacterial drugs resistance
INTRODUCTION
Being among the most prevalent microbial diseases, urinary tract infections (UTIs) can affect people of any age. There are different classifications for UTIs: healthcare associated urinary tract infections (HAUTI) and community associated urinary tract infections (CAUTI) (1).
UTIs can also be categorized into uncomplicated UTIs which mostly infect healthy individuals or those with no history of structural or neurological urinary tract abnormalities (2, 3) and complicated UTIs which involve factors attenuating urinary tract or the host’s defense system including situations like urinary tract obstruction, urinary retention due to neurological condition, suppressed immune system, renal failure, kidney transplant, gestation and the existence of foreign bodies such as calculi, drainage devices or indwelling catheters (4, 5).
Depends on the site of infection, UTIs are comprised of cystitis (bladder infection), pyelonephritis (kidney infection), prostatitis (prostate infection) and urosepsis, although bacteriuria is considered a probable typical symptom in all UTIs (6).
Uropathogenic Escherichia coli (UPEC) is considered as the dominant microorganism causing UTI. The microorganisms responsible for causing UTI are either Gram-negative or Gram-positive bacteria including Escherichia coli, Proteus mirabilis, Klebsiella species (Klebsiella pneumoniae), Serratia marseciens, Citrobacter species, Gardnerella vaginalis, Pseudomonas aeruginosa, Enterobacter species (Enterococcus faecalis), Streptococcus group B (GBS), Staphylococcus species (Staphylococcus saprophyticus), Staphylococcus aureus, Mycoplasma species, Urea plasma species and Candida spp. (6–9).
Depending on which virulence factors are expressed, UPEC’s ability of causing symptomatic UTIs will be affected. The major virulence factors of E. coli are either associated with the surface of the bacterial cell or secreted and exported to their site of action. Type 1 fimbriae (fimH), pyelonephritis– associated pilus (pap), and S fimbrial adhesion (sfa) are the adhesion factors which boost colonization through various processes.
Since type 1 fimbriae is expressed both in pathogenic and commensal isolates, it is hard to resolve its role in human diseases. In fact, the frequency of fimH gene would not alter if the isolates causing UTI have a high or low virulence. Although it has been proven that P fimbriae are responsible for the increase in early colonization of tubular epithelium by some mechanisms concerning inter bacterial binding and biofilm formation, type 1 fimbriae mediate the colonization of the center of tubule. P fimbriae, encoded by pap (pyelonephritis–associated pilus) operon, are the most significant mannose–resistant adhesions expressed by E. coli and will result in extra-intestinal infections (10).
Furthermore, S fimbrial adhesion encoded by sfa genes is considered a virulence factor. A recently documented virulence factor in UPEC isolates is aerobactin, a bacterial siderophore encoded by aer gene (11, 12).
The aim of this study was to determine the most prevalent virulence gene among fimH, pap, sfa and aer in E. coli isolated from patients with urinary tract infection and also to demonstrate antimicrobial susceptibility test (AST) using disk diffusion (Kirby–Bauer method) in northeast of Iran. Besides, the probable relationships among virulence factors and also between virulence factors and resistance to antimicrobial agents have been investigated.
MATERIALS AND METHODS
Bacterial isolates.
Three hundred E. coli strains were isolated from patients affected by UTIs from 17 different sections of Ghaem and Imam Reza hospitals in Mashhad, Iran, from August 2016 until February 2017.
To examine the collected urine samples, each was inoculated in EMB agar, MacConkey agar and Blood agar (Merk, Germany). Plates were incubated for 48 hours at 37°C. When E. coli isolates were confirmed after the cultures were proven positive for UTI (103–105 cfu/mL), the colonies were tested using Gram staining and related standard biochemical and microbiological analysis (including IMViC, SIM, etc.). The samples were stored at −70°C in Tryptic Soy Broth (TSB) medium supplemented with 10% glycerol.
DNA extraction.
A single colony of each isolate was suspended in 100 μL distilled water, boiled for 10 minutes and then centrifuged at 10,000 × g for 10 minutes. The supernatants were collected carefully and used as template DNA for PCR (13).
Multiplex PCR for virulence factors.
To amplify the genes which encode pyelonephritis associated pili (pap genes), S-family adhesions (sfa gene), type-1fimbriae ( fimH gene) and aerobactin (aer gene), a multiplex polymerase chain reaction (PCR) was employed. The primers used in the present study were the same as described by Baholo et al. (14).
The amplification reactions were carried out in a 50 μL reaction volume containing 5 μL 10 × PCR buffer, 5 mM dNTPs, 25 mM MgCl2, 5U of Taq DNA polymerase, 0.5 μM of each of the virulence gene-specific primers and 5 μL of template DNA using a thermal cycler (Astech, Ireland).
The amplification conditions included 32 cycles of a denaturation step at 94°C for 30 seconds, primer annealing at 54°C for 30 seconds and extension at 72°C for 1 minute. The extension time was ramped for an additional 3 seconds per cycle and a final extension step of 5 min at 72°C was performed. The PCR products were run in 1.5% agarose gel electrophoresis and gel was stained with green viewer (14).
Antimicrobial susceptibility testing.
Antimicrobial resistance of E. coli isolates was investigated using disk diffusion on Mueller-Hinton agar plates (Merck, Germany) according to the Clinical and Laboratory Standards Institute guidelines, version 2016. The tested antimicrobials (Mast Companies, UK) were: ampicillin (10 μg), gentamicin (10 μg), amikacin (30 μg), cefazolin (30 μg), cefepime (30 μg), ceftazidime (30 μg), cefuroxime (30 μg), nalidixic acid (30 μg), ciprofloxacin (5 μg), norfloxacin (10 μg), imipenem (10 μg), meropenem (10 μg) and trimethoprim-sulfamethoxazole (12.5/23.75 μg). The quality control organism was E. coli ATCC 25922.
Statistical analysis.
Data analysis was performed using SPSS software (SPSS 22). The relationship between different virulence factors and antimicrobial resistance was analyzed by Pearson Chi-squares teat or fisher exact test. P value of less than 0.05 was considered significant.
RESULTS
The average age of the patients was 47, with the oldest being a 93-year-old man and the youngest patients were 11 boys and 7 girls below one year old. Among 300 isolates, 193 were isolated from females (64.3%), while 107 isolates (35.7%) were obtained from males.
Multiplex PCR.
The presence of virulence factors were investigated by PCR (Fig. 1). Among 300 isolates, fimH was found in 235 isolates (78.4%), aer in 212 (70.5%), sfa in 41 (13.6%) and pap in 25 (8.2%). Ten isolates did not have any virulence factors (3.33%).
Fig. 1.

Electrophoresis of PCR product with different virulence patterns on 1.5% Agarose Gel; (a) Lanes M: 50-bpDNA ladder as the molecular size marker; lane1, 2, 6; UP7 (aer + fimH), lane 3; UP3 (sfa), lane 4; UP12 (aer + pap + fimH), lane5; UP4 (fimH).
Considering these 300 isolates, 94 isolates (31.3%) carried only 1 virulence gene, 168 isolates (56%) carried 2 virulence genes and 28 isolates (9.33%) were carriers of 3 virulence genes. The studied isolates showed 15 different virulence patterns which are shown as urovirulence profile (UP) in Table 1. The most prevalent urovirulence profiles were UP7 ( fimH + aer) and UP4 (fimH). Of 300 isolates, 142 (47.7%) carried fimH and aer and 58 isolates (19.5%) had only fimH. The least common virulence profiles were UP10 (sfa + fimH) and UP14 (aer + pap + sfa), which were found in one isolate.
Table 1.
Virulence genes’ patterns identified among 300 E. coli isolates
| UP | Virulence pattern | Number of isolates | Percentage % |
|---|---|---|---|
| UP1 | aer | 29 | 9.6 |
| UP2 | pap | 3 | 1 |
| UP3 | sfa | 4 | 1.3 |
| UP4 | fimH | 58 | 19.5 |
| UP5 | aer + pap | 3 | 1 |
| UP6 | aer + sfa | 12 | 4 |
| UP7 | are + fimH | 142 | 47.7 |
| UP8 | pap + sfa | 3 | 1 |
| UP9 | pap + fimH | 7 | 2.3 |
| UP10 | sfa + fimH | 1 | 0.3 |
| UP11 | aer + sfa + fimH | 3 | 1 |
| UP12 | aer + pap + fimH | 22 | 7.3 |
| UP13 | pap + sfa + fimH | 2 | 0.7 |
| UP14 | aer + pap + sfa | 1 | 0.3 |
| UP15 | none | 10 | 3 |
UP: Urovirulence profile
Antimicrobial susceptibility testing.
The highest resistance was detected in cephalosporins (n=194, 64.7%). The rates of resistance to the tested antibiotic were as follows: 102 isolates (34%) to trimethoprim-sulfamethoxazole, 93 isolates (31%) to fluoroquinolones, 46 isolates (15.3%) to aminoglycosides, 40 isolates (13.3%) to β-lactams and 23 isolates (7.8%) to quinolones. The lowest resistance was observed in carbapenems with only 4.4% (13 isolates).
Statistical analysis of the associations between virulence factors and antimicrobial resistance.
The relationship between different virulence factors and between virulence factors and antimicrobial resistance were checked by chisquare test and then analyzed by fisher exact test (Table 2, 3).
Table 2.
Relationship between virulence factors using chi square test
| Virulence factors | aer | pap | sfa | fimH |
|---|---|---|---|---|
| aer | ------ | 0.049* | 0.643 | 0.594 |
| pap | 0.049* | ------ | 0.005* | 0.354 |
| Sfa | 0.643 | 0.005* | ------ | 0 |
| fimH | 0.594 | 0.354 | 0 | ------ |
P<0.05 is significant.
Table 3.
Relationship between virulence factors and antimicrobial resistance using chi square test
| β-lactam | Quinolones | Aminoglycosides | Fluoroquinolones | Trimethoprim-Sulfamethoxazole | Carbapenem | Cephalosporin | |
|---|---|---|---|---|---|---|---|
| aer | 0.514 | 0.097 | 0.297 | 0.02* | 0.639 | 0.061 | 0.876 |
| pap | 0.45 | 0.363 | 1 | 1 | 0.585 | 1 | 0.012* |
| sfa | 1 | 0.101 | 1 | 0.348 | 0.067 | 0.603 | 0.171 |
| fimH | 0.621 | 0.757 | 0.639 | 1 | 0.723 | 0.657 | 0.597 |
P<0.05 is significant.
The statistical analysis showed a significant relationship between pap and aer (p=0.049), suggesting that most aer positive isolates were pap negative. There was a significant association between pap and sfa (p=0.005), showing that most pap negative isolates were sfa negative. Moreover, a significant relationship was observed between aer and fluoroquinolones (p=0.02), which indicated that the isolates carrying aer genes are susceptible to fluoroquinolones. Another notable relationship was reported between pap and cephalosporins (p=0.012), which revealed that whenever pap is absent, the isolate would become resistant to cephalosporins.
DISCUSSION
Escherichia coli is responsible for over 80% of urinary tract infections leading to renal failure in long term untreated conditions. UPEC pathogenicity can be affected by some virulence factors (15–17).
In our study, 300 E. coli isolates were isolated from 64.2% female patients and 35.7% from male patients. Farshad et al. and Staji et al. reported 62.5% of E. coli were isolated from females and 37.5% from males; in addition, Shah et al. detected 53% of E. coli from female patients and 37% from male ones. Likewise, Ghazvini et al. isolated 86% of E. coli from female patients and 14% from male patients. The reason for women to hold a higher percentage of UTIs might be ascribed to the fact that their urethra is not only shorter but also its orifice opening is closer to anus compared to men (18–21).
The adhesive subunit of type 1 fimbriae, fimH, was the most predominant virulence factor (78.4%), as Haghighatpanah et al. identified fimH in 74.4% of UPEC isolates (22). Among 12 studies which investigated the prevalence of fimH, 10 studies reported a high frequency of 64% to 100% for fimH. Only Hassan et al. and Bahalo et al. reported a low prevalence of 28% and 30% for fimH, respectively (14, 19, 22–32). In this study, most of the isolates carried fimH as fimbria factor; uropathogenic E. coli isolates, which cause a wide range of human UTIs, and infection following bacterial adhesion in which catch-bonds are significant. Furthermore, 0.1–2 mm long protein-aceous filaments located on the surface of the bacteria called type 1 pili act as mediators in the adhesion of bacteria to urothelial cells under flow conditions which is the initial phase of the infection (33).
The second most common factor was aer gene (70.5%). The highest rate for aer that has been reported in E. coli isolates is 90% in Tehran, Iran, while the lowest rate belongs to Shahr-e-kord, Iran, with only 12% of the isolates carrying the gene (14, 25); this data is based on 8 studies surveyed worldwide among which, four of them suggested the gene to have been present in over 50% of the isolates in Tunisia, Romania and Iran (26, 28, 29, 31, 34). Santo et al. reported a 76% rate for aer among 100 E. coli isolates in Brazil which is in agreement with our results (15).
S fimbrial adhesion factor (sfa) has been detected in 8 studies, 7 of which reported less than 50% sfa gene in the isolates (14, 20, 26, 29, 31). López-Banda et al. identified sfa in 74.1% of E. coli isolates in Mexico (27). Farshad et al. and Santo et al. reported an sfa rate of 14.6% and 19% respectively, in accordance with our results (13.6%) (15, 18).
The distribution of pap (8.2%) found among the studied isolates was lower than that of previously reported cases. Moreover, three studies identified pap to be > 50% and 13 studies detected it under 50% in isolates (14, 18–20, 26, 27, 29, 31, 32, 34–39). The highest and lowest rates for pap were 72% (Egypt) and 13% (Iran) (20, 32).
There seems to be a difference in the presence of different virulence factor genes such as fimH, aer, sfa and pap in E. coli isolates which can be attributed to regional geography, climate, diet, public health, customs and sampling techniques (40).
Firouzeh et al. discovered that 22.6% of the isolates carried only one virulence gene, 34.6% carried two virulence genes, 26% three of such genes and 3.5% four genes. In the present study, 31.3% of the isolates carried one virulence gene, 56% two genes and 9.33% three genes. The similarity between these two studies indicates that E. coli responsible for UTIs mostly carries two virulence genes (34). Various virulence factors are probably related to clinical signs of different diseases; fimH is associated with cystitis and descending infections, pap with pyelonephritis and ascending infections and sfa, hly or aer with primary sepsis (29).
Jalili et al. reported 20 different virulence patterns, out of which 6 patterns (UP3, 4, 5, 6, 11 and 15) were the same as the ones we have observed in our study. Tarchouna et al. (2013) detected 23 various virulence profiles from which 9 profiles (UP1, 4, 7, 8, 9, 10, 12, 14 and 15) existed in this study as well. Among the two studies mentioned and our study, two virulence patterns were exactly similar: UP4 ( fimH profile) with 19.53% rate in our study and 23% and 8.88% in the other two studies along with UP15 (no virulence gene) with 3.31% rate in our study and 10% and 8.88% in the two studies mentioned (29, 31).
Recently, the results of several studies in Iran suggest the following antibiotic resistance rates: 69.7%, 78.1%, 54% and 64.7% resistant to trimethoprim-sulfamethoxazole, 43.8%, 31.2% and 43 to norfloxacin, 40.9%, 43.7%, 34% and 61.3% to ciprofloxacin, 53%, 62.5% and 63% to nalidixic acid, 46.2%, 37.5%, 19% and 40% to gentamicin, 25%, 12.5% and 8% to amikacin, 12%, 6.12%, 0 and 0.7% to imipenem (22, 25, 37–39, 41).
Antibiotic resistance to cephalosporins had a wide range of 7.6% to 100%. The highest antibiotic resistance was to cefepime (100%) and the lowest resistance was to cefoxitin (7.6%). Most of the studies reported resistance rates to cephalosporins to be between 50% and 70% (8, 9, 17, 21, 25, 37–39, 42, 43).
Resistance to trimethoprim-sulfamethoxazole (34%) in our study was low, while it holds high rates of 48%, 56.1% and 84% in Kuwait, Mexico and New Delhi, respectively (9, 27, 44).
The highest rate of resistance to fluoroquinolones was 62.3% and the lowest resistance was 11.2%. In the present study, the resistance of E. coli isolates to fluoroquinolones (31%) was almost similar to those reported in Iran (34%) and Kuwait (31%) (9, 25, 27, 37, 38, 42).
In all studies, the antibiotic resistance rates to β-lactams and quinolones were > 50%. Only Moue et al. detected a 13.9% resistance to β-lactams in Bangladesh which is similar to our study (13.3%) (8, 37–39, 42–44).
Resistance to aminoglycosides covered a broad spectrum of 2% to 85.24% in all the studies; this resistance was 15.3% in our study which is similar to the findings of Sabir et al. (12.7%) and Pourzare et al. (12.5%) (8, 9, 17, 22, 25, 27, 37–39, 42, 43).
The lowest antibiotic resistance was observed in carbapenems like imipenem and meropenem (4.4%). Several studies reported <% resistance rate for carbapenems, which is similar to the results of our study (23, 27, 38, 39).
Administration of non-standard antibiotics and extensive use of various antibiotics in treating urinary tract infections can lead to different resistances to antibiotics such as increased resistance particularly to cephalosporins in developing countries (38).
If possible, it would be best to collect urine samples from various hospitals in different parts of the city or different cities of the province. Also, investigating a higher number of virulence factor genes is favorable.
CONCLUSION
Our results indicated that almost half of the isolates carried fimH and aer. fimH acted as colonization factor and aer was important in producing iron for uropathogenic E. coli. Understanding the antibiotic resistance in different geographical areas is important; therefore, the most effective antibiotic is chosen to treat urinary tract infections. Meanwhile, it is critical that the antibiotic of choice would not increase the antibiotic resistance. To promote improvement in future studies, it is recommended to collect more E. coli isolates from different hospitals and to investigate more virulence factors among these isolates. Furthermore, it is well advised to study the expression of the virulence genes using real time PCR.
REFERENCES
- 1.Wagenlehner F, Tandogdu Z, Bartoletti R, Cai T, Cek M, Kulchavenya E, et al. The global prevalence of infections in urology study: a long-term, worldwide surveillance study on urological infections. Pathogens 2016;5:10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Hooton TM. Uncomplicated urinary tract infection. N Engl J Med 2012;366:1028–1037. [DOI] [PubMed] [Google Scholar]
- 3.Nielubowicz GR, Mobley HL. Host–pathogen interactions in urinary tract infection. Nat Rev Urol 2010;7:430–441. [DOI] [PubMed] [Google Scholar]
- 4.Pallett A, Hand K. Complicated urinary tract infections: practical solutions for the treatment of multiresistant Gram-negative bacteria. J Antimicrob Chemother 2010;65 Suppl 3:iii25–33. [DOI] [PubMed] [Google Scholar]
- 5.Levison ME, Kaye D. Treatment of complicated urinary tract infections with an emphasis on drug-resistant gram-negative uropathogens. Curr Infect Dis Rep 2013;15:109–115. [DOI] [PubMed] [Google Scholar]
- 6.Smelov V, Naber K, Johansen TEB. Improved classification of urinary tract infection: future considerations. Eur Urol Suppl 2016;15:71–80. [Google Scholar]
- 7.Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol 2015;13:269–284. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Moue A, Aktaruzzaman SA, Ferdous N, Karim MR, Khalil M, Das AK. Prevalence of urinary tract infection in both outpatient department and in patient department at a medical college setting of Bangladesh. Int J Biosci 2015;7:146–152. [Google Scholar]
- 9.Sewify M, Nair S, Warsame S, Murad M, Alhubail A, Behbehani K, et al. Prevalence of urinary tract infection and antimicrobial susceptibility among diabetic patients with controlled and uncontrolled glycemia in Kuwait. J Diabetes Res 2016;2016:6573215. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Bien J, Sokolova O, Bozko P. Role of uropathogenic Escherichia coli virulence factors in development of urinary tract infection and kidney damage. Int J Nephrol 2012;2012:681473. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Pobiega M, Wojkowska-Mach J, Chmielarczyk A, Romaniszyn D, Adamski P, Heczko PB, et al. Molecular characterization and drug resistance of Escherichia coli strains isolated from urine from long-term care facility residents in Cracow, Poland. Medical science monitor. Med Sci Monit 2013;19:317–326. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Slavchev G, Pisareva E, Markova N. Virulence of uropathogenic Escherichia coli. J Cult Collect 2008–2009;6:3–9. [Google Scholar]
- 13.Aldous WK, Pounder JI, Cloud JL, Woods GL. Comparison of six methods of extracting Mycobacterium tuberculosis DNA from processed sputum for testing by quantitative real-time PCR. J Clin Microbiol 2005;43:2471–2473. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Bahalo S, Tajbakhsh E, Tajbakhsh S, Momeni M, Tajbakhsh F. Detection of some virulence factors of Escherichia coli isolated from urinary tract infection isolated of children in Shahrekord Iran by multiplex PCR. Middle-East J Scien Res 2013;14:29–32. [Google Scholar]
- 15.Santo E, Macedo C, Marin JM. Virulence factors of uropathogenic Escherichia coli from a university hospital in Ribeirao Preto, Sao Paulo, Brazil. Rev Inst Med Trop Sao Paulo 2006;48:185–188. [DOI] [PubMed] [Google Scholar]
- 16.Kudinha T, Kong F, Johnson JR, Andrew SD, Anderson P, Gilbert GL. Multiplex PCR-based reverse line blot assay to simultaneously detect 22 virulence genes in uropathogenic Escherichia coli. Appl Environ Microbiol 2011:78:1198–1202. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Akoachere J-FTK, Yvonne S, Akum NH, Seraphine EN. Etiologic profile and antimicrobial susceptibility of community-acquired urinary tract infection in two Cameroonian towns. BMC Res Notes 2012;5:219. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Farshad S, Emamghorashi F. The prevalence of virulence genes of E. coli strains isolated from children with urinary tract infection. Saudi J Kidney Dis Transpl 2009;20:613–617. [PubMed] [Google Scholar]
- 19.Ghazvini H, Taheri K, Edalati E, Sedighi M, Mirkalantar S. Virulence factors and antimicrobial resistance in uropathogenic Escherichia coli strains isolated from cystitis and pyelonephritis. Turk J Med Sci 2019;49:361–367. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Staji H, Rassouli M, Jourablou S. Comparative virulo-typing and phylogenomics of Escherichia coli isolates from urine samples of men and women suffering urinary tract infections. Iran J Basic Med Sci 2019;22:211–214. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Shah C, Baral R, Bartaula B, Shrestha LB. Virulence factors of uropathogenic Escherichia coli (UPEC) and correlation with antimicrobial resistance. BMC Microbiol 2019;19:204. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Haghighatpanah M, Mojtahedi A. Characterization of antibiotic resistance and virulence factors of Escherichia coli strains isolated from Iranian inpatients with urinary tract infections. Infect Drug Resist 2019;12:2747–2754. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Yun KW, Kim HY, Park HK, Kim W, Lim IS. Virulence factors of uropathogenic Escherichia coli of urinary tract infections and asymptomatic bacteriuria in children. J Microbiol Immunol Infect 2014;47:455–461. [DOI] [PubMed] [Google Scholar]
- 24.Watts RE, Hancock V, Ong C-LY, Vejborg RM, Mabbett AN, Totsika M, et al. Escherichia coli isolates causing asymptomatic bacteriuria in catheterized and noncatheterized individuals possess similar virulence properties. J Clin Microbiol 2010;48:2449–2458. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Raeispour M, Ranjbar R. Antibiotic resistance, virulence factors and genotyping of Uropathogenic Escherichia coli strains. Antimicrob Resist Infect Control 2018;7:118. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Usein CR, Damian M, Tatu-Chitoiu D, Capusa C, Fagaras R, Tudorache D, et al. Prevalence of virulence genes in Escherichia coli strains isolated from Romanian adult urinary tract infection cases. J Cell Mol Med 2001;5:303–310. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.López-Banda DA, Carrillo-Casas EM, Leyva-Leyva M, Orozco-Hoyuela G, Manjarrez-Hernández ÁH, Arroyo-Escalante S, et al. Identification of virulence factors genes in Escherichia coli isolates from women with urinary tract infection in Mexico. Biomed Res Int 2014; 2014: 959206. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Mladin C, Usein C-R, Chifiriuc M-C, Palade A, Slavu CL, Negut M, et al. Genetic analysis of virulence and pathogenicity features of uropathogenic Escherichia coli isolated from patients with neurogenic bladder. Rom Biotechnol Lett 2009;14:4906–4911. [Google Scholar]
- 29.Jalali HR, Pourbakhsh A, Fallah F, Eslami G. Genotyping of virulence factors of Uropathogenic Escherichia coli by PCR. NBM 2015;3:177–181. [Google Scholar]
- 30.Hojati Z, Zamanzad B, Hashemzadeh M, Molaie R, Gholipour A. The FimH gene in uropathogenic Escherichia coli strains isolated from patients with urinary tract infection. Jundishapur J Microbiol 2015; 8(2): e17520. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Tarchouna M, Ferjani A, Ben-Selma W, Boukadida J. Distribution of uropathogenic virulence genes in Escherichia coli isolated from patients with urinary tract infection. Int J Infect Dis 2013;17(6):e450–453. [DOI] [PubMed] [Google Scholar]
- 32.Hassan R, El-Naggar W, El-Sawy E, El-Mahdy A. Characterization of some virulence factors associated with Enterbacteriaceae isolated from urinary tract infections in Mansoura Hospitals. Egypt J Med Microbiol 2011;20:9–17. [Google Scholar]
- 33.Sauer MM, Jakob RP, Eras J, Baday S, Eriş D, Navarra G, et al. Catch-bond mechanism of the bacterial adhesin FimH. Nat Commun 2016;7:10738. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Firoozeh F, Saffari M, Neamati F, Zibaei M. Detection of virulence genes in Escherichia coli isolated from patients with cystitis and pyelonephritis. Int J Infect Dis 2014;29:219–222. [DOI] [PubMed] [Google Scholar]
- 35.El-Mosallamy WA, Desouky SM, El-Azm A, Abeer A, Abd El Hamid HS. Detection of some virulence factors and pyelonephritis-associated pilus (pap) encoding operon gene in Uropathogenic Escherichia coli. Egypt J Med Microbiol 2015;24:3;37–43. [Google Scholar]
- 36.Fathollahi S, Yousefi_Mashouf R, Goodarzi MT, Hajilooei M, Hemati S, Mostafaei A, et al. Typing of the uropathogenic E. coli strains using. Arch Clin Infect 2009;4:77–81. [Google Scholar]
- 37.Derakhshan S, Pourzare M, Roshani D. Distribution of virulence factors according to antibiotic susceptibility among Escherichia coli isolated from urinary tract infection. Indian J Nephrol 2018;28:191–197. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Pourzare M, Derakhshan S, Roshani D. Distribution of uropathogenic virulence genes in Escherichia coli isolated from children with urinary tract infection in Sanandaj, Iran. Arch Pediatr Infect Dis 2017;5(3):e41995. [Google Scholar]
- 39.Neamati F, Firoozeh F, Saffari M, Zibaei M. Virulence genes and antimicrobial resistance pattern in uropathogenic Escherichia coli isolated from hospitalized patients in Kashan, Iran. Jundishapur J Microbiol 2015; 8(2):e17514. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Karimian A, Momtaz H, Madani M. Detection of uropathogenic Escherichia coli virulence factors in patients with urinary tract infections in Iran. Afr J Microbiol Res 2012;39:6811–6816. [Google Scholar]
- 41.Hozzari A, Behzadi P, Khiabani PK, Sholeh M, Sabokroo N. Clinical cases, drug resistance, and virulence genes profiling in uropathogenic Escherichia coli. J Appl Genetics 2020; 61:265–273. [DOI] [PubMed] [Google Scholar]
- 42.Sabir S, Anjum AA, Ijaz T, Ali MA. Isolation and antibiotic susceptibility of E. coli from urinary tract infections in a tertiary care hospital. Pak J Med Sci 2014;30:389–392. [PMC free article] [PubMed] [Google Scholar]
- 43.Taheri M, Saleh M, Nemati AH, Ariana M, Shojaei E, Mardani M, et al. Antibiotic resistance pattern and phylogenetic groups of the Uropathogenic Escherichia coli isolates recovered from the urinary catheters of the hospitalized patients. JoMMID 2016;4:76–82. [Google Scholar]
- 44.Sharma S, Kaur N, Malhotra S, Madan P, Ahmad W, Hans C. Serotyping and antimicrobial susceptibility pattern of Escherichia coli isolates from urinary tract infections in pediatric population in a tertiary care hospital. J Pathog 2016;2016:2548517. [DOI] [PMC free article] [PubMed] [Google Scholar]
